Skip to search boxSkip to navigationSkip to main content

The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 187-198 (12 pages)

Journal (Volume, Issue Number)

Psychiatric Clinics of North America (Volume 39, Issue 2)

Publication milestones

  • Accepted/In press - 2016
  • Published - 06/01/2016

Publication status

Published - 06/01/2016

ISSN

0193-953X

Publication IDs

  • Scopus: 84958580496
  • PubMed: 27216899

Publication metrics

Metrics

Fractional count
2
Fractional count
1
Fractional count
2
Fractional count
1
Scopus
citations
SciVal
FWCI
1.58
SciVal
Author count
2
SciVal
citations
27
SciVal
Paper percentile
90
SciVal
Top percentile
10

PlumX, opens in new tab

Mentions
3
Citation count
43
Social media
14
Captures
95